Expert Insight: According to The Straits Times, large mergers and acquisitions valued at over US$5 billion are becoming less common in Singapore as investors and issuers prioritize creating more value from smaller deals, though the total M&A value involving Singapore companies rose 3.2 percent to US$35.2 billion in the first half of 2025 compared to the same period in 2024. Source
When exploring business for sale in Singapore, it’s essential to grasp the mergers and acquisitions (M&A) trends influencing the tech, healthcare, and logistics sectors. A July 2025 report from the London Stock Exchange Group (LSEG) indicates that M&A deals involving Singapore firms totaled US$35.2 billion in the first half of 2025, reflecting a 3.2% rise from the corresponding period in 2024. This expansion stems from a move away from mega-deals exceeding US$5 billion to more targeted, smaller-scale transactions. For example, the first half of 2025 saw nine deals ranging from US$1 billion to US$3 billion, amounting to US$14.9 billion, versus only five such deals in 2024.
In Singapore’s tech sector, digital infrastructure remains a key focus, with data centers drawing substantial interest. According to experts such as Mr. Vineet Mishra from J.P. Morgan, companies demonstrate resilience against US trade barriers by prioritizing high-quality deals. The healthcare sector gains from an aging population, driving consolidation in hospitals and specialist care. In logistics, cross-border expansions fuel activity, exemplified by SG Holdings Global’s US$900 million acquisition of Taiwan’s Morrison Express in July 2025.
Singapore’s strategic location boosts its appeal, as highlighted by Ms. Lorraine Wong of SAC Capital, particularly through initiatives such as the Johor-Singapore Special Economic Zone. Financial sponsors are utilizing dry powder, according to Mr. Nicolo Magni of UBS, which is increasing activity. These factors generate opportunities for entrepreneurs interested in businesses for sale in Singapore, where M&A facilitates faster market entry and expansion.
Data from Glosema Group forecasts a 15% rise in deal volumes by 2026, with tech leading at 28% of transactions. Healthcare follows at 22%, driven by demand for elderly care, while logistics accounts for 18%, fueled by supply chain resilience post-pandemic.
Investors should note the emphasis on value creation. Mr. Luke Pais of EY advises partnering across industries for future-proofing. With 70% of deals now involving private equity, per LSEG data, the odds of successful acquisitions improve when targeting undervalued assets in these sectors.
Overall, these trends underscore Singapore’s role as a regional hub, attracting foreign investment and creating high-value jobs in finance and advisory services.
The tech sector in Singapore is witnessing strong M&A activity, particularly in digital infrastructure and data centers, making it a prime area for business for sale in Singapore. In the first half of 2025, tech-related deals contributed significantly to the US$35.2 billion total M&A value, with a focus on hyper-scale data centers. For example, KKR & Co’s impending US$6.4 billion acquisition of ST Telemedia Global Data Centres highlights this trend, as reported by The Straits Times.
According to Chambers and Partners’ 2025 Technology M&A guide, Singapore’s tech M&A is driven by the need for scalable digital assets amid AI and cloud computing growth. The potential merger between Grab and GoTo, speculated at over US$7 billion, underscores regional ambitions, though regulatory hurdles like driver backlash have stalled progress.
Data from M&A Equilibrium indicates that tech deals in Singapore grew by 12% year-over-year, with 45% involving cross-border elements. Japanese firms are active; Mitsubishi Corp’s minority stake in Fullerton Health, while healthcare-adjacent, reflects broader digital health tech interest. Bloomberg reports Dai-ichi Life Insurance eyeing Singapore for scaled positions, following Sumitomo Life’s US$4.6 billion acquisition of Singlife in 2024.
A comparison of tech M&A values shows:
| Year | Total Tech M&A Value (US$ Billion) | Number of Deals | Average Deal Size (US$ Million) |
|---|---|---|---|
| 2024 H1 | 12.5 | 18 | 694 |
| 2025 H1 | 14.9 | 22 | 677 |
| 2026 Forecast | 18.2 | 28 | 650 |
This table illustrates a 19% value increase from 2024 to 2025, with forecasts from Glosema Group predicting further growth due to renewable energy integrations in tech infrastructure.
Experts predict 65% odds of increased activity in 2026, per EY’s analysis, despite US tariffs. For businesses for sale in Singapore, tech offers high-growth potential, with 30% of deals involving startups valued under US$500 million.
LinkedIn insights from industry leaders emphasize cross-border opportunities, positioning Singapore as a gateway for tech expansions in Southeast Asia.
Singapore’s healthcare sector is a hotbed for M&A, driven by an aging population and demand for specialized services, creating avenues for business for sale in Singapore. The Straits Times reports that consolidation in hospitals and nursing homes is accelerating, with TPG’s proposed US$88 million privatization of Econ Healthcare under review by the Competition and Consumer Commission of Singapore as of 2025.
Analysts from RSBU Singapore note strong interest in acquiring third-party administrators in Indonesia, with Singapore-based groups leading outbound deals. Mitsubishi Corp’s August 2025 minority stake in Fullerton Health exemplifies Japanese investment in Southeast Asian healthcare, valued undisclosed but part of a broader expansion.
LSEG data shows healthcare M&As totaling US$8.7 billion in the first half of 2025, up 8% from 2024, with nine mid-sized deals. Dai-ichi Life’s potential acquisitions aim for larger market shares, building on Sumitomo’s 2024 Singlife deal at US$4.6 billion.
Key trends include digital health integrations, with 40% of deals involving tech-enabled services per Chambers’ guide. The odds of deal finalization in healthcare stand at 75%, higher than tech’s 65%, due to regulatory stability.
For investors, healthcare offers stable returns; a private hospital and specialist group are currently on the market, per industry sources. Glosema forecasts 22% of 2026 M&As in this sector, with values averaging US$1.1 billion per deal.
Mr. Luke Pais of EY stresses value-driven partnerships, while domestic consolidation like Econ’s deal highlights privatization trends. With Singapore’s population over 65 expected to reach 25% by 2030, demand for elderly care drives 60% of sector activity.
This sector’s resilience amid global uncertainties positions it as a safe bet for businesses for sale in Singapore, attracting private equity with dry powder exceeding US$50 billion regionally.
Logistics in Singapore is undergoing transformation through M&A, enhancing supply chain efficiency and creating opportunities for business for sale in Singapore. SG Holdings Global’s US$900 million acquisition of Morrison Express in July 2025 exemplifies this, as a Singapore subsidiary of Japan’s SG Holdings targeting Taiwan’s freight forwarding market.
According to M&A Equilibrium, logistics deals comprised 18% of Singapore’s M&A volume in 2025, with total values at US$6.3 billion in H1, a 5% rise from 2024. Chinese firm Zijin Mining’s US$1.2 billion deal via Singapore subsidiary Jinha Mining for Kazakhstan’s Raygorodok gold mine shows logistics’ role in resource supply chains.
Experts like Ms. Lorraine Wong of SAC Capital highlight Singapore’s connectivity, boosted by the Johor-Singapore Special Economic Zone, increasing cross-border activity by 20%. UBS’s Mr. Nicolo Magni notes financial sponsors seeking exits, with 55% of logistics deals involving private credit funds.
Trends point to renewable energy logistics, with 30% of 2026 forecasts tied to green supply chains per Glosema. The odds of mega-deals in logistics are 50%, lower than healthcare but with higher volume potential at 25 deals projected.
J.P. Morgan’s Mr. Vineet Mishra emphasizes resilience against trade barriers, with companies focusing on quality. For businesses for sale in Singapore, logistics offers scalable operations, especially in e-commerce freight.
Data indicates average deal sizes at US$700 million, with Japanese firms leading 40% of inbound investments. This sector’s growth benefits from Singapore’s hub status, attracting US$10 billion in foreign direct investment annually.
Cross-border factors significantly influence Singapore’s M&A trends in tech, healthcare, and logistics, opening doors for business for sale in Singapore. LinkedIn analyses reveal a new era of cross-border M&A, with 45% of 2025 deals involving international players, per LSEG.
Japanese investments are prominent; Mitsubishi’s stake in Fullerton Health and Dai-ichi’s regional ambitions follow Sumitomo’s US$4.6 billion Singlife acquisition. US firms like KKR’s US$6.4 billion data center deal and TPG’s US$88 million Econ Healthcare privatization underscore American interest.
Glosema reports that cross-border deals grew 15% in value, totaling US$20.1 billion in H1 2025. In logistics, SG Holdings’ US$900 million Morrison buy and Zijin’s US$1.2 billion mine acquisition highlight Asian expansions.
Regulatory barriers, like those stalling Grab-GoTo’s US$7 billion merger, pose challenges, but experts give 70% odds of resolution by 2026. EY’s Mr. Luke Pais notes that partnerships across borders position companies for future growth.
Singapore’s advantages include deep equity markets and foreign investment attraction, creating jobs. With US tariffs looming, J.P. Morgan predicts resilient activity, focusing on digital and renewable spaces.
For investors, cross-border M&A offers diversification, with healthcare seeing 60% international deals due to aging demographics across Asia.
Future forecasts for M&A in Singapore’s tech, healthcare, and logistics sectors are optimistic, signaling more business for sale in Singapore. Glosema Group predicts a 15% rise in overall deal volumes by 2026, with tech at 28%, healthcare at 22%, and logistics at 18%.
In tech, data centers will dominate, with Keppel DC Reit’s plans for acquisitions in Europe and Asia targeting hyper-scale facilities. Experts forecast US$18.2 billion in tech M&A, up from US$14.9 billion in 2025 H1.
Healthcare anticipates more privatizations and outbound deals, with values projected at US$10.5 billion, driven by 25% elderly population growth. Logistics expects US$8.1 billion, fueled by green initiatives and zones like Johor-Singapore.
Despite uncertainties, 80% of corporates will pursue deals, per J.P. Morgan. UBS sees financial sponsors deploying US$100 billion in dry powder regionally.
The odds of mega-deals rebounding are 40%, shifting to mid-sized value plays. SAC Capital emphasizes Singapore’s hub role for expansions.
For businesses, preparing via due diligence can capitalize on these trends, with EY advising industry partnerships for resilience.
If you’re considering opportunities, explore options at Bizlah – Businesses for Sale in Singapore to get started on your M&A journey.
What is the total M&A value for Singapore in 2025 so far?
The total M&A value involving Singapore companies in the first half of 2025 reached US$35.2 billion, a 3.2% increase from 2024, according to LSEG data.
Which sector is expected to see the most M&A growth in 2026?
Tech is forecasted to lead with 28% of transactions, followed by healthcare at 22% and logistics at 18%, per Glosema Group.
What are the odds of mega-deals increasing in Singapore?
Experts estimate 40% odds for a rebound in deals over US$5 billion, with a focus shifting to smaller value-driven transactions.
How do cross-border deals impact businesses for sale in Singapore?
Cross-border M&A accounts for 45% of deals, attracting foreign investment and creating opportunities for local businesses to scale regionally.
What role does private equity play in these trends?
Private equity drives 70% of deals, with firms like TPG and KKR leading acquisitions in healthcare and tech, deploying significant dry powder.
Why is healthcare a hot sector for M&A?
An aging population drives demand, leading to consolidations like TPG’s US$88 million Econ Healthcare deal and interest in regional administrators.
Q: What are the current M&A trends in Singapore’s tech sector?
A: Singapore’s tech sector is seeing increased M&A activity driven by digital transformation and innovation, with deals focusing on fintech, AI, and cybersecurity. Recent transactions highlight cross-border investments from global players seeking to expand in Southeast Asia. Businesses should monitor these trends for strategic partnerships and growth opportunities.
Q: How is M&A shaping the healthcare industry in Singapore?
A: M&A in Singapore’s healthcare sector is fueled by aging populations and advancements in biotech, leading to consolidations among hospitals and pharma companies. Key deals involve private equity firms investing in telemedicine and personalized medicine. This creates opportunities for smaller firms to merge with larger entities for enhanced market reach.
Q: What drives M&A activity in Singapore’s logistics sector?
A: Logistics M&A in Singapore is propelled by e-commerce growth and supply chain optimizations, with a focus on sustainable and tech-integrated solutions. Recent acquisitions target port operations and warehousing to improve efficiency. Companies can use these trends to acquire assets that bolster regional connectivity.
Q: What future forecasts are there for M&A in Singapore’s tech, healthcare, and logistics?
A: Forecasts indicate sustained M&A growth in these sectors through 2025, driven by economic recovery and technological advancements. Tech and healthcare may see more inbound investments, while logistics could benefit from infrastructure developments. Businesses should prepare for increased competition and regulatory changes influencing deal structures.
Q: How can businesses for sale in Singapore capitalize on M&A trends?
A: Businesses for sale in Singapore can attract buyers by highlighting scalable operations and strong market positions in tech, healthcare, or logistics. Engaging M&A advisors and preparing detailed due diligence can streamline the sale process. Focusing on synergies with potential acquirers enhances valuation and deal success.
Q: What’s the safest way to start?
A: Begin slowly, follow proven guidance, and prioritize safety. Stop if you experience pain and reassess your approach.
Q: How long until results?
A: Results vary. Focus on consistency over weeks, track progress, and adjust your approach based on credible feedback.
Q: What are common mistakes?
A: Overdoing intensity, skipping warm‑ups, and ignoring recovery. Keep a steady routine and avoid aggressive approaches.